Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04136613
Other study ID # 9 Al-KindyCM
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 1, 2015
Est. completion date June 1, 2019

Study information

Verified date January 2020
Source Al-Kindy College of Medicine
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Iraq is a country that ranks 33rd around world population growth rate. Meanwhile it is one of the counties in the middle east with the highest fertility rate, In addition to the considerable number of unintended pregnancy mainly in postpartum period.

The less use of family planning methods, the higher the fertility rate and the less interpregnancy interval which will carry an obvious more risk to the mother and the fetus especially if the cesarean delivery rate shown an increase trend as the case in Iraq. For that reason, contraception needs to be practiced in this critical period and an intrauterine contraceptive device ( IUD), the most commonly used reversible method of contraception worldwide could be an excellent choice during this period.

There were few evidences available about the safety and feasibility on practicing this type of contraception when we did start three years ago and no previous evidences in Iraq about practicing this method at the immediate postpartum period.


Description:

Setting and design:

It is a single arm prospective clinical trial. That had been conducted at Al Elweyia Maternity Teaching Hospital and Al Hayat Private Hospital in Baghdad during the period from Sept., 1st, 2015 to Jan.,1st, 2019. Women delivering in those hospitals fulfilling inclusion criteria were included in the study after obtaining informed consent. The study protocol was approved by the ethical committee.

Data collection:

180 women were enrolled in the study, only 150 of them completed the study as thirty women we couldn't reach them through their contact numbers.

Intervention:

They had immediate post-partum insertion of Copper IUD (Cu-T 380A) after delivery of placenta immediately at cesarean delivery. To overcome the considerable expulsion rate in the previous studies, we stabilize the IUD in place at the uterine fundus by an absorbable suture; vicryl 0 that was introduced through the fundus ( from out to in), held the needle with sponge holder that was introduce up the fundus and taken out the vicryl through the lower uterine incision, cutting the needle, warped the vicryl around the the T arm of the IUD and withdrawn back to be placed inside the uterine cavity near the fundus. Before closing the uterine incision, the threads were placed in the lower uterine segment, then the uterine incision was closed routinely.

Follow up:

Women were assessed before discharge from the hospital looking for any excessive bleeding and were provided with a mobile number to call, in case she has any problem with the device that had been inserted.

Women were reassessed at six weeks postpartum, where speculum examination was done and if IUD threads was seen, they were trimmed at 2 cm from external os, otherwise if the threads of IUD were not seen a pelvic ultrasonography was done to confirm the presence of IUD in situ.

Women then were reassessed at yearly intervals for 3 years, looking for the occurrence of excessive bleeding during subsequent menstruation, for abdominal pain and abnormal vaginal discharge, missed threads, expulsion rate, continuation rate and how far they do recommend this method of contraception for other women.

Statistical analysis:

The data analyzed using Statistical Package for Social Sciences (SPSS) version 25. The data presented as mean, standard deviation and ranges. Categorical data presented by frequencies and percentages. Chi square test was used to assess the association between complication of IUD and certain information. Significance level was set at P < 0.05.


Recruitment information / eligibility

Status Completed
Enrollment 150
Est. completion date June 1, 2019
Est. primary completion date January 1, 2019
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 45 Years
Eligibility Inclusion Criteria:

- Women who delivered by caesarean section whether elective or emergency, counseled for IUD insertion in pre- natal period or at the time of labour and who has the will and her husband to be engaged in the study.

Exclusion Criteria:

- Women with positive test for STIs (e.g. gonorrhea or chlamydia) in this pregnancy.

- Uterine anomaly that was known to distort the uterine cavity; whether uterine fibroid or congenital uterine anomalies.

- Developed postpartum hemorrhage.

- Diagnosed chorioamnionitis, intrapartum fever, or ruptured membranes for greater than 24 hours prior to delivery.

- Placenta previa or accrete.

- Anemia during pregnancy (Hb < 10 g/dl).

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Copper Intra uterine contarceptive device ( Cu-T 380A)
Insertion of the Cu-T 380A during cesarean delivery immediately after placental removal.

Locations

Country Name City State
Iraq Al Kindy College of Medicine/ University of Baghdad Baghdad

Sponsors (2)

Lead Sponsor Collaborator
Taghreed Alhaidari Elweyia Maternity Teaching Hospital

Country where clinical trial is conducted

Iraq, 

Outcome

Type Measure Description Time frame Safety issue
Primary Number of the women accept to be engaged in this services. Assessing the acceptability of the women for the service of IUD insertion during the immediate postpartum period after cesarean delivery. First 6 months of the study
Primary Cost of IUD insertion during the immediate postpartum period. Assessing the cost for the insertion of the device in the immediate postpartum period. Up to 3 years.
Primary Time spent for IUD insertion during the immediate postpartum period Assessing the extra time spent for the insertion of the device in the immediate postpartum period. Up to 3 years
Secondary Percentage of Immediate complications Number of the women having immediate complications including excessive blood loss before discharge from the hospital. First 48 hours post cesarean section.
Secondary Percentage of other complications Number of the women having heavy menstrual blood loss, abdominal pain, abnormal vaginal discharge, missed threads, perforation and expulsion rate. Six months and yearly up to 3 years
See also
  Status Clinical Trial Phase
Recruiting NCT05889689 - Evaluation of an Adolescent Pregnancy Prevention Program; Relationship Smarts+ With Lessons From Mind Matters N/A
Withdrawn NCT03725358 - A Cluster-RCT to Increase the Uptake of LARCs Among Adolescent Females and Young Women in Cameroon. N/A
Completed NCT02234271 - Plan A Birth Control: Randomized Controlled Trial of a Mobile Health Application for Contraception Information N/A
Enrolling by invitation NCT05216003 - Pregnancy at a Time That Is Happy and Healthy for You N/A
Not yet recruiting NCT03612518 - An mHealth Trial to Promote the Use of Postpartum Contraception N/A
Completed NCT03366636 - Project Legacy Impact Evaluation Study N/A
Recruiting NCT06100679 - Responsible Engaged and Loving (REAL) Fathers Intervention Evaluation N/A
Completed NCT03775642 - Debunking Myths About Contraceptive Safety Among Women in Kingston, Jamaica N/A
Completed NCT03571932 - Assessment of Family Planning and Immunization Service Integration in Liberia
Completed NCT03165838 - Effectiveness of Shortened Time Interval to Postpartum Visit in Improving Postpartum Attendance N/A
Completed NCT04120376 - Reducing Adolescent Pregnancy N/A
Completed NCT03400410 - Hormonal Contraceptive Health Education for Adolescent Males N/A
Not yet recruiting NCT05988983 - The Over The Counter Pill National Study
Not yet recruiting NCT05362019 - Effects of One-to-one Service on the Continuation and Satisfaction of Contraceptive Use. N/A
Completed NCT01360216 - Cluster, Randomized Trial on Long Acting Reversible Contraception (LARC) Education and Training N/A
Completed NCT03559634 - Contraception Initiation Feasibility in the Pediatric ED N/A
Enrolling by invitation NCT05022134 - Evaluating the Impact of CHOICE-AYA on Contraceptive Use, Continuation and Satisfaction N/A
Active, not recruiting NCT03733678 - A Randomized-Controlled Trial to Increase the Uptake of LARCs in Cameroon N/A
Completed NCT03500978 - Factors Predicting Ineffective Contraception Use N/A
Recruiting NCT06307002 - Evaluating What's My Method? in Barbados N/A